From: Higher fasting triglyceride predicts higher risks of diabetes mortality in US adults
 | All participants (N = 26,582) | Participants without diabetes (N = 22,909) | Participants with diabetes (N = 3673) | ||||||
---|---|---|---|---|---|---|---|---|---|
HR | 95% CI | P value | HR | 95% CI | P value | HR | 95% CI | P value | |
Model 1 | 2.62 | 2.33–2.94 | < 0.001 | 2.22 | 1.77–2.78 | < 0.001 | 1.32 | 1.14–1.54 | <  0.001 |
Model 2 | 2.35 | 2.05–2.68 | < 0.001 | 1.77 | 1.37–2.28 | < 0.001 | 1.47 | 1.24–1.75 | <  0.001 |
Model 3 | 2.12 | 1.84–2.45 | < 0.001 | 1.51 | 1.15–1.99 | 0.003 | 1.39 | 1.17–1.67 | <  0.001 |
Model 4 | 1.40 | 1.20–1.64 | < 0.001 | 1.45 | 1.09–1.92 | 0.011 | 1.32 | 1.09–1.58 | 0.004 |